Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Cortical gray matter atrophy in healthy aging cannot be explained by undetected incipient cognitive disorders: a comment on Burgmans et al. (2009).

Fjell AM, Westlye LT, Espeseth T, Reinvang I, Dale AM, Holland D, Walhovd KB.

Neuropsychology. 2010 Mar;24(2):258-63; discussion 264-266. doi: 10.1037/a0018827.

2.

The prevalence of cortical gray matter atrophy may be overestimated in the healthy aging brain.

Burgmans S, van Boxtel MP, Vuurman EF, Smeets F, Gronenschild EH, Uylings HB, Jolles J.

Neuropsychology. 2009 Sep;23(5):541-50. doi: 10.1037/a0016161.

PMID:
19702408
3.

Loss of fornix white matter volume as a predictor of cognitive impairment in cognitively normal elderly individuals.

Fletcher E, Raman M, Huebner P, Liu A, Mungas D, Carmichael O, DeCarli C.

JAMA Neurol. 2013 Nov;70(11):1389-95. doi: 10.1001/jamaneurol.2013.3263.

4.

Aging does not affect gray matter asymmetry.

Smeets F, Vuurman EF, van Boxtel MP, Burgmans S, Gronenschild EH, Uylings HB, Jolles J.

Psychol Aging. 2010 Sep;25(3):587-94. doi: 10.1037/a0017849.

PMID:
20853966
5.

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M.

Arch Neurol. 2009 Sep;66(9):1144-50. doi: 10.1001/archneurol.2009.174.

PMID:
19752305
6.

Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease.

Mungas D, Reed BR, Jagust WJ, DeCarli C, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC.

Neurology. 2002 Sep 24;59(6):867-73.

7.

News of cognitive cure for age-related brain shrinkage is premature: a comment on Burgmans et al. (2009).

Raz N, Lindenberger U.

Neuropsychology. 2010 Mar;24(2):255-7. doi: 10.1037/a0018828.

8.

Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.

Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC.

JAMA Neurol. 2013 Jul;70(7):903-11. doi: 10.1001/jamaneurol.2013.1062.

PMID:
23712469
9.

The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease.

Prestia A, Baglieri A, Pievani M, Bonetti M, Rasser PE, Thompson PM, Marino S, Bramanti P, Frisoni GB.

Suppl Clin Neurophysiol. 2013;62:67-80.

PMID:
24053032
10.

The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition.

Bakkour A, Morris JC, Wolk DA, Dickerson BC.

Neuroimage. 2013 Aug 1;76:332-44. doi: 10.1016/j.neuroimage.2013.02.059. Epub 2013 Mar 16.

11.

Longitudinal MRI and cognitive change in healthy elderly.

Kramer JH, Mungas D, Reed BR, Wetzel ME, Burnett MM, Miller BL, Weiner MW, Chui HC.

Neuropsychology. 2007 Jul;21(4):412-8.

12.

Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects.

Cook IA, Leuchter AF, Morgan ML, Conlee EW, David S, Lufkin R, Babaie A, Dunkin JJ, O'Hara R, Simon S, Lightner A, Thomas S, Broumandi D, Badjatia N, Mickes L, Mody RK, Arora S, Zheng Z, Abrams M, Rosenberg-Thompson S.

Arch Neurol. 2002 Oct;59(10):1612-20.

PMID:
12374500
13.

Longitudinal volumetric MRI change and rate of cognitive decline.

Mungas D, Harvey D, Reed BR, Jagust WJ, DeCarli C, Beckett L, Mack WJ, Kramer JH, Weiner MW, Schuff N, Chui HC.

Neurology. 2005 Aug 23;65(4):565-71.

14.

Glucose hypometabolism is highly localized, but lower cortical thickness and brain atrophy are widespread in cognitively normal older adults.

Nugent S, Castellano CA, Goffaux P, Whittingstall K, Lepage M, Paquet N, Bocti C, Fulop T, Cunnane SC.

Am J Physiol Endocrinol Metab. 2014 Jun 1;306(11):E1315-21. doi: 10.1152/ajpendo.00067.2014. Epub 2014 Apr 15.

15.

Neuropathological basis of magnetic resonance images in aging and dementia.

Jagust WJ, Zheng L, Harvey DJ, Mack WJ, Vinters HV, Weiner MW, Ellis WG, Zarow C, Mungas D, Reed BR, Kramer JH, Schuff N, DeCarli C, Chui HC.

Ann Neurol. 2008 Jan;63(1):72-80.

16.

Brain aging, cognition in youth and old age and vascular disease in the Lothian Birth Cohort 1936: rationale, design and methodology of the imaging protocol.

Wardlaw JM, Bastin ME, Valdés Hernández MC, Maniega SM, Royle NA, Morris Z, Clayden JD, Sandeman EM, Eadie E, Murray C, Starr JM, Deary IJ.

Int J Stroke. 2011 Dec;6(6):547-59. doi: 10.1111/j.1747-4949.2011.00683.x.

PMID:
22111801
17.

Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer disease.

Freeman SH, Kandel R, Cruz L, Rozkalne A, Newell K, Frosch MP, Hedley-Whyte ET, Locascio JJ, Lipsitz LA, Hyman BT.

J Neuropathol Exp Neurol. 2008 Dec;67(12):1205-12. doi: 10.1097/NEN.0b013e31818fc72f.

18.

The correlation of cognitive decline with frontotemporal dementia induced annualized gray matter loss using diffeomorphic morphometry.

Avants B, Grossman M, Gee JC.

Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19 Suppl 1:S25-8.

PMID:
16317254
19.

Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica.

Wang Q, Zhang N, Qin W, Li Y, Fu Y, Li T, Shao J, Yang L, Shi FD, Yu C.

AJNR Am J Neuroradiol. 2015 Oct;36(10):1822-9. doi: 10.3174/ajnr.A4403. Epub 2015 Sep 3.

20.

Parahippocampal volume deficits in subjects with aging-associated cognitive decline.

Pantel J, Kratz B, Essig M, Schröder J.

Am J Psychiatry. 2003 Feb;160(2):379-82.

PMID:
12562591

Supplemental Content

Support Center